GovChime
AWARDDELIVERY ORDEROther than small business

Delivery order 75F40120F19003ACUMEN LLC

Overview

Award facts

Net obligations
$15.78M
$15,784,030of $15.78M potential value
Outlays (paid to date)
$11.26M
$11.26M paid of $15.78M obligated$11,260,491
Period of performance
Sep 24, 2020 to Sep 29, 2023
Ended
Modifications
9
Latest action Jan 23, 2025
Contract type
Delivery order
PIID 75F40120F19003

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE: DATA, TOOLS AND INFRASTRUCTURE FOR SURVEILLANCE OF BIOLOGICS

Dates and value

Award date
Signed on Sep 24, 2020
Potential end of performance
Sep 28, 2023
Current value
$15,784,030Base and exercised options
Potential value (if all options are exercised)
$15,784,030
Parent contract vehicle
75F40118D10020 (IDC, multiple award) — 5 orders recorded under it

Obligations by fiscal year of action

  • FY2025: -$62,988 (de-obligation)
  • FY2023: -$77,014 (de-obligation)
  • FY2022: $4,866,965
  • FY2021: $6,430,367
  • FY2020: $4,626,699

Total across 5 fiscal years: $15,784,030

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jan 23, 2025. View on USAspending · Recipient on SAM.gov

Recipient

NameACUMEN LLC
LocationBURLINGAME, CA
UEIXVMTJF1497P1
CAGE code3MQD9
Business sizeOther than small businessSize at award, per the contracting officer
Organization typePartnership
Parent companyACUMEN LLC

Business types and certifications

For-profit organizationLimited liability companyPartnership or LLP

Self-reported at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Cures activities; Human drugs; Biologics; Coronavirus emergency funding supplemental; Fda user fees (non general fund)Program activities075-0600, 075-5629Federal accounts (agency financial reports)

Place of performance

Place of performance
Burlingame, San Mateo County, California 94010-1980
Congressional district (place of performance)
CA-15As reported at the time of the action

Classification and competition

Classification

NAICS
518210COMPUTING INFRASTRUCTURE PROVIDERS, DATA PROCESSING, WEB HOSTING, AND RELATED SERVICES
Product or service (PSC)
B537SPECIAL STUDIES/ANALYSIS- MEDICAL/HEALTH (service)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Subject to multiple award fair opportunityMAFO
Set-aside
Not reported
Contract pricing
Time and materialsY
Offers received
1

Solicitation and notices

Solicitation ID
1224001(as reported)
Solicitation date
Mar 3, 2020

Contract details

Subcontracting plan
Individual subcontract planF
Certified cost or pricing data
No
Service Contract Act labor standards
Yes
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Sep 24, 2020Base obligation at award: $4,626,699
Latest action
Jan 23, 2025 — CloseoutModification P00009; obligation change -$62,988; administrative: no change in scope or value
Latest substantive action
Jan 4, 2023 — Supplemental agreement (within scope)Modification P00008; obligation change -$77,014
Actions by type
  • Base award1
  • Supplemental agreement (within scope)4
  • Option exercised2
  • Other administrative action2
  • Closeout1
10 actions recorded, Sep 24, 2020 to Jan 23, 2025; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$62,988
Latest action: change in base and all options
-$62,988

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Delivery orderC
Parent vehicle type
IDCB
Parent vehicle: multiple or single award
Multiple awardM
Parent vehicle agency
Food And Drug Administration7524
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
10

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2020/2020-0600-000
  • 075-2022/2022-0600-000
  • 075-X-0600-000
  • 075-X-5629-000
Object classes
  • 25.2: Other services from non-Federal sources
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
  • V: Non-emergency P.L. 117-2
COVID-19 supplemental obligations
$6,334,597
COVID-19 supplemental outlays
$6,334,597